MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Venus Concept Cash Conversion Cycle 2011-2026 | VERO
Annual Cash Conversion Cycle Venus Concept
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 404 | 446 | 381 | 380 | 420 | 297 | 159 | 87.8 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 446 | 87.8 | 322 |
Quarterly Cash Conversion Cycle Venus Concept
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 333 | 287 | 366 | - | 404 | 434 | 404 | - | 490 | 456 | 442 | - | 477 | 430 | 417 | - | 443 | 405 | 421 | - | 455 | 581 | 683 | - | 475 | 455 | 511 | 518 | 181 | 171 | 130 | 60.2 | 111 | 79.7 | 78.3 | 43.7 | 49.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 683 | 43.7 | 348 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abbott Laboratories
ABT
|
101 | $ 102.87 | 0.48 % | $ 179 B |  USA |
 |
Align Technology
ALGN
|
137 | $ 170.6 | -1.23 % | $ 12.8 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Alphatec Holdings
ATEC
|
240 | $ 10.83 | -3.82 % | $ 1.63 B | USA |
 |
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
245 | $ 34.44 | 2.56 % | $ 1.59 B | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
ClearPoint Neuro
CLPT
|
217 | $ 9.37 | 2.52 % | $ 265 M | USA |
 |
Accuray Incorporated
ARAY
|
184 | $ 0.42 | 6.82 % | $ 43.2 M | USA |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | USA |
 |
Cytosorbents Corporation
CTSO
|
104 | $ 0.58 | 6.52 % | $ 36.1 M | USA |
 |
Delcath Systems
DCTH
|
258 | $ 9.63 | 0.94 % | $ 345 M | USA |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
180 | $ 23.29 | -1.52 % | $ 197 M | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 36.76 | 1.88 % | $ 5.48 K | USA |
 |
Boston Scientific Corporation
BSX
|
107 | $ 62.82 | 1.32 % | $ 93 B | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Edwards Lifesciences Corporation
EW
|
283 | $ 81.05 | -0.26 % | $ 47.4 B | USA |
 |
CONMED Corporation
CNMD
|
212 | $ 34.79 | -2.08 % | $ 1.08 B | USA |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Aethlon Medical
AEMD
|
-61.8 | $ 2.12 | -1.4 % | $ 3.31 M | USA |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
20.1 | $ 12.03 | 1.43 % | $ 1.63 B | USA |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 1.86 | 9.41 % | $ 1.13 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 9.53 | -0.42 % | $ 734 M | USA |
 |
Inogen
INGN
|
48.9 | $ 6.21 | -0.96 % | $ 165 M | USA |
 |
Inspire Medical Systems
INSP
|
248 | $ 54.99 | 2.52 % | $ 1.61 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
714 | $ 16.06 | -1.41 % | $ 377 M | USA |
 |
IRIDEX Corporation
IRIX
|
105 | $ 0.98 | 3.17 % | $ 16.6 M | USA |
 |
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | USA |
 |
Integer Holdings Corporation
ITGR
|
96.8 | $ 86.85 | 0.47 % | $ 3.02 B | USA |
 |
LivaNova PLC
LIVN
|
113 | $ 63.79 | -1.3 % | $ 3.48 B |  Britain |
 |
LENSAR
LNSR
|
85.4 | $ 6.06 | 1.51 % | $ 72.5 M | USA |